Funding for this research was provided by:
Triangle Comparative and Evolutionary Medicine Center, Duke University
Duke Global Health Institute, Duke University
National Institute of Allergy and Infectious Diseases (K23AI125677)
FDA GenomeTrakr program (1U18FD00678801)
Received: 13 December 2020
Accepted: 21 April 2021
First Online: 30 April 2021
: Ethical approval for this study was obtained from the Faculty of Medicine, University of Ruhuna, Ethical Review Committee (Sri Lanka) and the Duke University Institutional Review Board (USA).
: Not applicable.
: The authors declare that they have no competing interests.